Clinical trials
Renal Insufficiency trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
53 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 6 |
| 2010 | 6 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Active, not recruiting | 6 |
| Terminated | 5 |
| Recruiting | 4 |
| Unknown status | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Hospital Clinic of Barcelona | 3 |
| Abbott Medical Devices | 2 |
| Akebia Therapeutics | 2 |
| Guerbet | 2 |
| Takeda | 2 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Achieve Life Sciences | 1 |
| Advanz Pharma | 1 |
| Amicus Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 53 |
| Renal Insufficiency, Chronic | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Fibrosis | 6 |
| Kidney Diseases | 6 |
| Anemia | 5 |
| Heart Failure | 5 |
| Kidney Failure, Chronic | 5 |
| Cardiovascular Diseases | 4 |
| Coronary Artery Disease | 3 |
Trials
Showing 76 to 53 of 53. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.